Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
Sleep deprivation leads to increased production of free fatty acids and triglycerides. World Sleep Day special ...
Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...
NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...
However, cardiovascular diseases remain the primary cause of death in MAFLD patients, and individuals with MAFLD are at ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
SLIM LIVER was the first clinical trial to test semaglutide as a treatment for MASLD in people living with HIV. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a common and ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Unexpectedly, the study found that lean patients with NAFLD had a higher risk of developing heart disease than non-lean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback